Form 4 for MAZE Maze Therapeutics, Inc.
Accepted 2026-09-03 16:31:00 ET · period of report 2026-09-01 · accession 0001782758-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-03 16:31 | 2026-09-01 | MAZE | Courtney Phillips | GC, Corp. Sec | M - OptEx | $0.00 | +11.0K | 11.0K | New | $0 |
| D | 2026-09-03 16:31 | 2026-09-01 | MAZE | Courtney Phillips | GC, Corp. Sec | M - OptEx | $0.00 | -11.0K | 11.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | M | A | 11,000 | $0.00 | 11,000 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2026-09-01 | M | D | 11,000 | $0.00 | 11,000 | D | — · — to — | 11,000 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F2) The award vested or vests as to 1/2 of the total award on September 1, 2026 and September 1, 2027, subject to the reporting person's continued service to the Issuer on each vesting date. (F3) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |